Subscribe to our E-Newsletter

Stay up-to-date on the latest news about prostate cancer. Join our distribution list to receive periodic email updates and our monthly e-newsletter.

- test

Surgery vs Radiation for High-Risk Prostate Cancer

High-risk prostate cancer (PCa) is well defined, but opinions vary on whether radical prostatectomy or radiation therapy is the best... Read More

Active Surveillance Required After Prostate Cancer Focal Ablation

Active surveillance of untreated regions of the prostate is mandatory for men undergoing focal ablation for prostate cancer (PCa) based... Read More

Clinicians Embrace New Prostate Cancer Grading System

First described in a paper published 4 years ago, the new Gleason grade group system for the risk classification of... Read More

Overuse of Prostate Cancer Scans May Be Easing

Studies published in the past few years have documented overuse of radiologic imaging, such as bone and computed tomography (CT)... Read More

Prostate Cancer Pathologic Stage Alone Independently Predicts BCRFS

Only pathologic staging is independently associated with biochemical recurrence-free survival (BCRFS) following radical prostatectomy (RP) for prostate cancer, according to the findings... Read More

Testosterone Patterns Predict Prostate Cancer Risk

Prostate cancer (PCa) may be more likely to develop in men who experience large drops or fluctuations in testosterone levels,... Read More

IMRT for Prostate Cancer Radiation Therapy Soars

Over an 11-year period from 2002 to 2012, the largest increase in the use of various radiation therapy modalities occurred... Read More

Prostate Cancer Active Surveillance Use Low, But Increasing

Despite National Comprehensive Cancer Network (NCCN) guidelines that recommend active surveillance (AS) for men with very low-risk prostate cancer, overall use... Read More

New Prostate Cancer Biomarkers Can Improve Precision Therapy

Improvements are on the horizon in the treatment of prostate cancer that could improve future therapy. Read more.

Cancer Patient Self-Reporting Reliable and Feasible, Studies Show

Men with newly diagnosed prostate cancer (PCa) can reliably report their comorbidities, and participants in cancer clinical trials “are willing and able”... Read More

1 2 3 5